Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
We are performing the above prospective randomized trial in 1'000 patients undergoing cardiac
surgery. The study will answer the question of whether preoperative treatment of anemia or
iron deficiency indeed improves transfusion needs (primary outcome) and important clinical
outcomes (secondary outcome) in a large group of cardiac surgical patients. The list of
inclusion and exclusion criteria was deliberately chosen short so that this patient group
largely reflects today's clinical practice .
- Trial with medical product
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Treatments:
Epoetin Alfa Ferric Compounds Folic Acid Hydroxocobalamin Iron Vitamin B 12 Vitamin B Complex Vitamins